Ubumenyi ku bihereranye na Science ya Cannabis hamwe n’Amayeri mu gufasha abaturage: Gutsinda mu Bitaraboneka bya Ruremwo hamwe na OilWell

Murakaza neza inshuti zacu n’abigishwa b’ubuzima hose mu Karere ka Ngozi.

Turiko OilWell Cannabis, itsinda rishingiye ku misuro ry’abahanga mu bya siyanse, abahanga mu bikorwa remezo n’abigisha baturutse muri Houston, muri Texas. Nubwo imisozi irangwamo amahoro n’umutekano n’imidugudu y’Amajyaruguru ya Burundi ari kure y’urugo rwacu, ishyirwa mu bikorwa ryacu ryo kugeza ubumenyi ku bijyanye na cannabis ku Isi hose ritarenze imipaka. Ntituzana, kohereza cyangwa dusaba abantu gukoresha cannabis mu bihugu byaziririjwe. Ahubwo twihara umwete wo gusangiza ubumenyi bukomoka ku siyanse, amateka n’inyigisho z’amayeri mu gufasha abantu zituruka kuri cannabis hamwe n’ibindi bimera nk’ubunyobwa bwo mu butaka. Iyi nkuru yerekanwa mu rwego rw’amasomo n’uburezi, ku burenganzira bw’amategeko agenga ibihugu byose, harimo n’ibyo Burundi iziririje.

Urugendo rwacu rutangiriye mu kibanza cy’abahanga mu bya siyanse, ariko mu nzu imbere y’akabwa gatererwa kwitwa Bentley. Mu gihe abahanga mu buvuzi b’amatungo basaba ko cyicwa, twasanze ubushobozi budahari mu gukiza buturuka mu cannabinoids. Iki gihamya nyamwinshi – kureba akabwa cyavuzwe ko gicirirwe kugenda, guhaguruka, ndetse n’akina nyuma y’imyaka icumi – ni byo byatumye dusanga imico ikwiye. Twaremera ko ubumenyi ari ingenzi, kandi gusobanukirwa sisitemu ya endocannabinoid rusange yo mu mubiri ni uburenganzira bw’umuntu, utagira aho aba. Iyi nyandiko ishimangira uburezi bwagutse ku bijyanye na siyanse ya cannabinoids, terpenes, n’ubunyobwa bwo mu butaka, binyuze mu makuru y’ubushobozi bw’imiti twakurikiza n’ubushakashatsi buryohereza imyumvire yacu. Twagira icyo tubigenzura dutinya Imana kandi dukomeje kubahiriza umuco k’akarere ka Ngozi n’amategeko agenga aho.

Gucengera mu By’ukuri ku Isi ku bijyanye na Cannabis: Inyandiko ku Birebana n’Ibiba mu Mategeko

Imiterere y’amategeko agenga cannabis ni ikintu gikomeye ku Isi hose, gihindagurika cyane hagati y’ubutegetsi n’ubundi. Muri Leta Zunze Ubumwe z’Amerika, 2018 Farm Bill yashyizeho ingingo z’igihugu zisobanuranya ibigori (bivuze cannabis ifite urugero rwa Delta-9 THC runoze kuri 0,3% ku bijyanye n’ibiro) na marijuana. Ibyo byemeje ko bimera byavanye n’ibigori, kugurishwa, no koherezwa mu bihugu byemewe, harimo novel cannabinoids nka THCa na Delta-8 THC, byemewe niba bivuye mu bigori byujuje ibisabwa. Muri iki cyemezo gishya cy’igihugu cy’ubuhinzi ni ho dukorera muri Houston.

Mu gihombo, muri Burundi, cannabis mu buryo bwose iranzwe. Igihugu gikurikiza amategeko y’igihugu y’ishingiro n’amasezerano ku Isi yose yo kurwanya ubujura bigenga cannabis nk’ikintu kiziririjwe. Ibihano byo gushyira mu maboko, gukoresha cyangwa kwirakwiza cannabis biranuka. Twatangaje neza kandi udakomeza ko iyi nkuru si ugutegeka guhohotera amategeko ya Burundi. Ni ugushakisha uburezi buby’ubumenyi ku bimera, siyanse y’ibinyabuzima, no gukomeza guhindura uko ibihugu byinshi byumva aya makomoko. Twemera kandi tubahiriza ubwigenge bw’amategeko mu gihugu cya Republika y’u Burundi hamwe n’ububasha bwa Ngozi muri cyo.

Uburayi nk’ishyanga rifite ubufatanye bw’iminsi ya kera buri ku kigoryi, cannabis sativa, hamwe n’imikorere yacyo muri amateka mu mico itandukanye mu minsi mikuru, mu gutunganya impuzu n’amayeri mu gufasha abantu. Uyu munsi, imiterere y’amategeko ku gihugu yari ihenze. Ibihugu bifitanye isano birimo gukurikirana ubushakashatsi bukomeye mu buvuzi n’imvururu z’impinduka. Nubwo Burundi ikomeje kwanga cannabis, gusobanukirwa ikoreshwa rya siyanse mu buryo burambuye ni ingenzi. Intego yacu aha ni ugutanga amakuru y’ukuri, ashimangiye ku bushakashatsi, mu nama y’Isi yose, dushingiye ku bumutsi, ubwiza n’uburezi usimburanya uburyo bwose bwo gushishikariza abantu bibuza amategeko.

Ingingo zishingiye ku Siyanse: Sisitemu ya Endocannabinoid (ECS) – Umuhinzi w’Umubiri wanyu wo gukomeza Uburinganire

Kugira ngo dusobanukirwe impamvu cannabinoids ziva mu kigoryi zikora n’umubiri w’umuntu, bigomba tangira gusobanukirwa sisitemu y’ibinyabuzima yahise mu 1990: Sisitemu ya Endocannabinoid (ECS). Iyi si sisitemu ya cannabis; ni sisitemu y’ingenzi yo mu mubiri ihari muri bose b’abantu hamwe n’inyamanswa zose zikomeye, kandi yitwa inyuma y’ikimera cyatwaye abahanga mu bya siyanse.

ECS ni urusobe rw’ibimenyetso by’imiti n’ubushobozi bwo kwakira (CB1 na CB2) birimo ubwonko n’umubiri wawe. Umumaro wayo w’ibanze ni homeostatasi – gukomeza imiterere itandukanye mu mubiri n’ibindi biri hanze. Tekereza nk’umuyobozi mukuru w’umubiri ku:

• Kumva Uburibwe n’Ubukana
• Imiterere, Imihangayiko, n’Ingaruka z’Imyumvire
• Imikurire y’Icyicaro n’Uburinganire bw’Ingufu
• Ibitekerezo n’Ubushishozi
• Ibiryo no Kurya
• Umumaro w’Sisitemu y’Ubuzima
• Gukurikirana n’Guhuza

Umubiri wawe urema cannabinoids zawo, bita endocannabinoids (nk’anandamide, “molekile y’umunezero”). Cannabinoids zivanye mu bimera, cyangwa phytocannabinoids, zimeze neza. Iyo ziri mu mubiri, zishobora gukorana n’iyi sisitemu izi, zigafasha mu bumaro bwazo bwo kubungabunga. Ibi bisobanura ubwoko bumwe bw’ingaruka cannabis ishobora kugira – zikorana na sisitemu ifite inshingano zo kugumana umubiri mu buryo bukwiye.

Gusobanukirwa neza ku bintu by’ingenzi bya Cannabinoids: Siyanse y’Ibinyabuzima n’Ubushakashatsi

Ibi bikurikira ni ibisobanuro by’uburezi ku bahinjirira bya cannabinoids, imiterere yazo y’ibinyabuzima, n’ubushakashatsi bwo mu mashuri y’uburezi bujyanye n’ubumenyi bwazo bwo gukorana n’ECS. Ibi ni by’ingenzi mu misi yacu y’amasomo.

1. Cannabidiol (CBD) – Inkomoko y’Ubushakashatsi bwa Kigezi ku Cannabis

• Inkomoko y’Ibinyabuzima: C₂₁H₃₀O₂
• Guhise: Yahise mu 1940 na Dk. Roger Adams muri kaminuza ya Illinois.
• Imiterere y’Siyanse: CBD ntabwo irwara kandi ikorana n’urusobe runini rw’ubushobozi bwo kwakira uretse CB1 na CB2. Ikora nk’umuyobozi wa allosteric w’ubushobozi bwo kwakira CB1 (bivuze ko ishobora guhindura uko ubushobozi bwo kwakira bukora kubindi bimumyesha), agonist ikomeye ya serotonin receptor 5-HT1A (ihuzwe n’imihangayiko n’imiterere), n’umuyobozi wa TRPV1 channels (ihuzwe n’uburyo bwo kumva uburibwe n’ubukana).
• Ubushakashatsi Bw’ingengo: Icyemezo gihambaye cyane cyaje hamwe na 2018 FDA yemera Epidiolex, umuti w’ubushyuhe bwa CBD, kubyara ibibazo by’uburibwe mu bana nka Dravet na Lennox-Gastaut syndromes. Isesengura rya 2017 ryakozwe n’Ikigo cy’ubuhanga mu bya siyanse, mu buhinzi, n’umuti, rigaragaje ko hari “ibimenyetso byihujije cyangwa byinshi” byerekana ko cannabis irafasha mu kurwanya uburibwe mu bantu bakuru n’ibikomere bya chemotherapy.
• Ibanga ry’Umutekano: CBD ni inhibitor ikomeye y’amashusho amwe ya cytochrome P450 mu hini (cyane cyane CYP2C19 na CYP3A4). Ibi ni ubumenyi bw’ingenzi mu buvuzi, kuko bivuze ko CBD ishobora guhindura uko imiti ikora no kugera ku mibare y’amaraso ya miti myinshi ikunzwe, harimo ibikomere by’amaraso (warfarin), imiti ikumira ibibazo by’uburibwe (clobazam), n’imwe y’imiti icumbika. Uburezi bukwiye bugomba kuba urimo iyi nkuru.

2. Tetrahydrocannabinolic Acid (THCa) – Intangiriro ifite Ubushobozi Budasanzwe

• Inkomoko y’Ibinyabuzima: C₂₂H₃₀O₄
• Siyanse yo Guhindura: Mu kigoryi gikozwe, hejuru ya 90% bya THC ishobora kuba irimo THCa, aside carboxylic. Mu mihango yitwa decarboxylation – gukoresha ubushyuhe (nk’igishanga, gufata ikirere, cyangwa gukora) – itsinda rya aside rimanurwa nka CO₂, guhindura THCa kuba Delta-9 THC ya siyanki. Guhindura ni hagati ya 87,7% by’ingoga.
• Uburezi bwa Makuru yombi: Iyi siyanse yerekana inzira ebyiri zitandukanye:
  • THCa Yisukuye/Igitaka: Iyo iriwe mu kanwa (urugero, mu muti wo kunywa cyangwa umutobe ushye), ntacyirwara. Ubushakashatsi bwa mbere, harimo ubushakashatsi bwa National Institutes of Health (NIH), buravuga ko THCa ubwayo ifite ubushobozi bukomeye. Ubushakashatsi bwa NIH bwa 2023 bwerekanye ko ari byo bishingiye ku bushobozi bukomeye mu kurwanya ibikomera mu mihango ya colon binyuze mu gukumira COX-2. Ubushakashatsi bwa NIH bwa 2024 bwagaragaje THCa nk’agonist ikomeye ya PPARγ receptor, inzira ingenzi mu kubungabunga ibikomera, gufata neza inshilizi, n’ubuzima bw’ibinyabuzima, kandi yavuze ko ifite ubushobozi bwo gukingira ubwonko.
  • THCa Yashyuhe/Decarboxylated: Ibi bibumba Delta-9 THC, ishobora gukorana n’inzira z’ubushobozi bwo kwakira CB1.
• Ibirebana n’amategeko muri Amerika: Kubera ko amategeko y’igihugu ya Amerika (2018 Farm Bill) agomba gusa Delta-9 THC mu bigori, ibimera byinshi bya THCa n’ibikorwa byavanye mu bigori bihingwa kandi bigurishwa mu buryo bwemewe n’igihugu. Ibi ni ingingo y’ingenzi mu bihinduranya bya kigezi by’ubuhinzi mu Amerika.

3. Cannabigerol (CBG) – “Cannabinoid Nyina”

• Inkomoko y’Ibinyabuzima: C₂₁H₃₂O₂
• Uruhare mu Biosynthesis: Mu kigoryi, cannabinoids nyinshi (THC, CBD, CBC) zitangirira nka cannabigerolic acid (CBGa), bigatanga CBG izina ryo kuba “nyina”. Iyo iboneka mu mimerere, iraboneka mu mibare nkeya (<1%) mu bimera byakuze.
• Gukorana Runini n’Ubushobozi bwo Kwakira: CBG irakora neza kuri zombi ubushobozi bwo kwakira CB1 na CB2, ariko ubushakashatsi bwayo bwiza buri hanze. Ikora nk’agonist kuri ubushobozi bwo kwakira alpha-2 adrenergic (bimeze nk’imwe y’imiti ikumira imihangayiko n’amaraso) hamwe n’ inhibitor ikomeye ya GABA reuptake. GABA ni neurotransmitter y’ibanze mu bumenyi bw’umubiri; kongera iboneka rwayo ni ubushobozi bwo gukora imiti ikumira imihangayiko nka benzodiazepines, ariko udafata ubushobozi bwo kwakira.
• Ibyiza vya Ubushakashatsi bwa vuba: Ubushakashatsi bw’ingengo bwa 2024 bwakozwe mu kigo cya Washington State University (N=34) bwagaragaje ko 20mg y’CBG yagabanyije imihangayiko. By’ingenzi, ubwo bushakashatsi bwagaragaje ko CBG yongereye bitekerezo – impinduka itandukanye n’izo THC zisanzwe zihuzwa. Ubushakashatsi bw’ingengo bwakozwe na NIH mu 2024 bwagaragaje ingaruka za CBG mu gukingira ubwonko ku bijyanye n’amakuba ya amyloid-beta (ahuzwe n’ubushakashatsi bwa Alzheimer) hamwe n’ubushobozi bwayo bukomeye bwo kurwanya ibikomera byangiritse nka MRSA.

4. Cannabinol (CBN) – Umushinga w’Uburara

• Inkomoko y’Ibinyabuzima: C₂₁H₂₆O₂
• Gukora: CBN ni ibisohoka bya THC, bikorwa nk’uko cannabis igezeho cyangwa ihura n’ikirere cy’umwuka n’ubushyuhe.
• Guhinduka mu Siyanse y’Icyicaro: Mu myaka irenga makumyabiri, izina rya CBN ry’uburara ryari rishingiye ku mateka. Mu mpera za 2024, abashakashatsi muri kaminuza ya Sydney basohoye ibimenyetso bya mbere by’ubushakashatsi mu mihango y’inyamanswa bwerekana ko CBN yongereye ibice byombi by’icyicaro NREM na REM, n’ingaruka zimeze nk’iz’umuti witwa zolpidem (Ambien). Ibyo byakurikijwe n’ubushakashatsi bw’ingengo bwakozwe mu bantu (Oxford Academic, Mata 2024, N=1000+) bwagaragaje ko 50mg ya CBN yagira neza cyane mu cyicaro kuburyo bwihuse ugereranyije n’ikintu kidakoreshwa. Ibi bituma CNG iba ya mbere ya cannabinoid ifite amakuru ashingiye ku buvuzi mu gufasha mu cyicaro.

5. Cannabichromene (CBC) – Umufasha wa Neurogenesis

• Inkomoko y’Ibinyabuzima: C₂₁H₃₀O₂
• Uburyo Budasanzwe: Nk’uko THC cyangwa CBD, CBC ifite ubushobozi buke bwo gufata CB1/CB2. Ahubwo, ishyira mu bikorwa neza TRPV1 na TRPA1 receptors (abakinnyi b’ingenzi mu kumenyekanisha uburibwe) kandi ni inhibitor ikomeye ya anandamide reuptake, bityo ikongera urwego rw’iyi cannabinoid yacu yo mu mubiri y’”umunezero”.
• Ubushakashatsi Bwite: Isesengura rikomeye rya 2024 riva muri kaminuza ya Penn State ryagaragaje ko ifite “ubushobozi budasanzwe mu gukiza”. Igikorwa cya mbere, nk’ubushakashatsi bwa 2013 muri Neurochemistry International, bwagaragaje ko iyongera ubushobozi bwo gukora neza abantu bakuru bafite ibyimbitse by’ubwonko (NSPCs), bifasha mu gukora neurogenesis (gukora neuron nshya) mu hippocampus, icyiciro cy’ubwonko gikomeye ku bitekerezo n’ubushishozi.

6. Delta-8-Tetrahydrocannabinol (Delta-8 THC) – Isomer Yoroheje ya Siyanki

• Inkomoko y’Ibinyabuzima: C₂₁H₃₀O₂ (isomer ya Delta-9 THC)
• Imiterere: Delta-8 THC iboneka mu mibare nkeya mu mimerere ariko ikunze gukorwa mu guhindura CBD iva mu bigori. Ifata ubushobozi bwo kwakira CB3 hamwe n’ubushobozi buke ugereranyije na Delta-9 THC, ibituruka mu mpinduka zasanzwe zivugwa nk’ijwi risobanutse kandi ritagira amakuba.
• Imiterere Ishingiye ku Bushakashatsi: Ubushakashatsi bwa 2022 muri Journal of Cannabis Research (N=521) bwakoresheje abakoresha mu bihugu 38 bya Amerika. Bwagaragaje ko 74% batavuze ko bafite amakuba kandi 83% batavuze ko bafite amakuba by’urupfu rwa Delta-8, ugereranyije n’ibyo bahuraga na Delta-9. Ubushakashatsi bwa mbere bwari harimo ubushakashatsi bwa mbere bwa 1995 mu bana aho Delta-8 THC yari 100% ikora mu kurinda ibikomere bya chemotherapy mu bana bafite imyaka 3-13, nta mpinduka z’ubwonko zavuzwe.

7. Uruhare rw’Ingingo ku Terpenes: Ingaruka y’Urwego rw’Abafatanyabikorwa Yahamijwe

Terpenes ni ibintu byumvikana bifatika bifatika mu bimera byose, bikora iyo cannabis yinjira, ubusitu bw’ibiti by’imisase, n’imbuto z’icunga. Ntizigomba kuba ziri mu cannabis gusa ariko zigira uruhare runini rwo gufatanya.

• Myrcene: Terpene ikunzwe cyane mu cannabis ya kigezi. Ubushakashatsi bwo mbere bushyira mu bikorwa ko ifite ubushobozi bwo burarisha n’ubwo kongera ubushobozi mu misipu. Ikunzwe naho kugira ngo yongere ubushobozi bwo kwinjira mu gipimo cy’amaraso kugirango cannabinoids zinjyiremo neza.
• Limonene: Ihagaze mu kigina cy’imbuto z’icunga. Ubushakashatsi bwa kigezi bwa 2024 bwakozwe na Johns Hopkins University (N=20) bwatanze ibimenyetso bya mbere by’ingaruka y’urwego rw’abafatanyabikorwa. Bwagaragaje ko abasabye 15mg ya terpene ya D-limonene hamwe na 30mg ya THC bahuraga n’igabanuka rikomeye rya 54,8% mu “kumva amakuba/imihangayiko” no mu “kumva amakuba” ugereranyije na THC wenyine. Ibi ni ibimenyetso byihariye, bigaragaza ko terpenes zihindura neza ingaruka za cannabinoids.
• Beta-Caryophyllene (BCP): Terpene y’ibiryo ihagaze muri pilipili nziza n’umusaraba. Ni idasanzwe nk’terpene yahamijwe ihari gusa ifata ubushobozi bwo kwakira CB2, ikora ingaruka zo kurwanya ibikomera udafite ubwonko. Ubushakashatsi bwa 2024 bwagaragaje uruhare rwayo mu kugabanya ibikomera by’ibinyabuzima (nka TNF-α na IL-6) hamwe n’ubushobozi bwayo bwo gukingira ubwonko mu mihango y’uburwayi bw’ubwonko nk’Parkinson na Alzheimer.
• Linalool: Ihagaze mu cyatsi kibisi. Ikora n’ubushobozi bwo kwakira GABA, bifasha mu kwiruhuka. Ubushakashatsi ku bantu binyuze mu gufata umuyaga w’icyatsi kibisi (kirimo linalool cyinshi) bwagaragaje ko bakeneye morphine nkeya cyane mu kurwanya uburibwe.

Gukorana hamwe kw’urwego rumwe, kwifatanya kwa cannabinoids na terpenes – aho ingaruka y’ikigoryi yose ni ingenzi ugereranyije n’imibare ya za ndetse – ni byo bita Ingaruka y’Urwego rw’Abafatanyabikorwa. Ubushakashatsi bwa Johns Hopkins ku limonene ni igihamya cya mbere cy’iyi ngingo.

Umuvuduko wa OilWell: Kuva ku Gahwa Gatererwa Kugeza ku Misuro y’Umutekano w’Umutekano w’Imiti

Imyumvire yacu yose y’ubucuruzi yavukiye mu kibazo cy’ubuvuzi bw’umuntu. Akabwa ka pitbull k’umwanzuro, Bentley, cyari cyatererwe mu maguru ya nyuma kandi cyasabaga ko cyicwa nk’uburyo bwa mbere bwo kuvurwa, kuko imiti ikumira uburibwe yari igomba kurimbura iby’umubiri. Ikibazo cy’umuntu wari warokoye – “Wahinduye toni zingana ikihe cya cannabis kandi ntabwo wigeze uvw ibyerekeye CBD?” – byatumye dushaka ubumenyi mu buryo bwo kurwana.

Mu bushakashatsi bukomeye no gukora imiti, “paste y’izahabu” yakoze: ikora imiti y’ubwonko y’ibihingwa, amavuta y’igikoma, pilipili nziza (kugirango iboneke), n’amavuta ya CBD yakemewe neza. Ibyabaye byerekanye ibyo twitegereje. Bentley, wari watewe igihombo kwezi, yahagurutse, yatangiye kugenda, n’agenda atwara umupira we. Yabayeho imyaka icumi yuzuye, akora ibintu byinshi, araca apfa mu buryo bwiza afite imyaka 20.

Iyo myaka icumi yari igihe cyacu cyo gushakisha no gukora. Nk’uko Bentley yari umaze imyaka, twakoze imiti yihariye y’uburwayi bw’ubwonko, ibyazo, n’indwara z’amaso. Buri gihingwa cya OilWell uyu munsi ni ikurikirana ry’iyo miti y’ubwenge, ifite ubushishozi bwinshi. Iyi nkuru ni yo mpamvu dukora mu buryo bwo “kubanza umurwayi”, kubanza uburezi usimburanya ubucuruzi, kandi ishyirwa mu bikorwa ryacu ry’ubuzima ari ikintu kidashoboka guhindurwa. Ibyo byagaragajwe na ABC News muri Houston, bituma tuzwi nk’abigisha, batari abacuruzi.

Kuzwi na Mediya Nyinshi: Ishyirwa mu Bikorwa ry’Ubuziranenge

Umurimo wacu w’uburezi wagize igihe cyinshi ABC13 News muri Houston, nk’icyemezo cy’uburyo bwacu bworoshye:

• Mu 2019, twongeyeho gukoresha abakoresha no kurwanya ibikorwa by’”snake oil” mu isoko ya CBD iri gukura.
• Mu 2021, twatanze ibisobanuro ku bijyanye na Delta-8 THC, tubivugaho mu buryo bw’ukuri mu gihe duhura n’ibibazo by’amategeko.
• Muri uwo mwaka umwe, twerekanye ishyirwa mu bikorwa ryacu mu muryango binyuze mu gutanga ibicuruzwa by’agaciro karenza miliyoni 35 Frw nk’inyigisho z’ubuvuzi bwa COVID-19, dushyiraho ubuzima bw’abaturage usimburanya inyungu.
• Twakomeje gushyigikira guhindura ibyemezo by’ubuvuzi ku bijyanye na cannabis, umwanzuro wacu avuga mu buryo bworoshye ibyaha byo hambere kugira ngo ahawe icyo areba mu guhinduranya uburyo bwo kurwanya ibyaha.

Inkomoko y’Ibidukikije: Amavuta ya Rick Simpson (RSO) Yahinduwe

Inkuru ya Amavuta ya Rick Simpson (RSO) ni igice gikomeye mu mateka ya cannabis. Mu masezerano ya mbere ya 2000, umuhanga mu buhinzi wo muri Kanada Rick Simpson yakoresheje amavuta ya cannabis yihariye mu gukira indwara ze zo ku ruhu, avuga ko yabonye amajwi meza. “Porotokole ya 60-gram” ye hamwe n’ubushishozi bwe byarakwirakwijwe ku Isi hose binyuze mu filime “Run From the Cure”. Nyamara, RSO ya kera yahuraga n’ibibazo: ko yari iziririjwe, gusuzugurika, gukora neza, no gukoresha ibintu byangiza.

Intego yacu yari gukora ahanini ibikorwa by’ubuvuzi, byemewe n’igihugu, byubahiriza ingingo ya Simpson yo gukora ibihingwa byose hagati aho bitanga ibisubizo by’ibi bibazo. Amavuta ya THCa Rick Simpson ni umugambi wose w’iyo ntambwe.

Uburyo bwacu Budasanzwe bwa THCa RSO (Amavuta yo Kunywa):
Burundi bupfundo bwa 30mL bufite 16,590mg bya cannabinoids byose, conserit ya cannabinoids itandatu ihamijwe:

• CBD: 4,500mg – Inkomoko y’ibikomera n’imihangayiko.
• Delta-8 THC: 6,000mg – Siyanki y’ibanze ifite neza mu kugabanya amakuba.
• CBG: 3,000mg – “Cannabinoid nyina” yo gukingira ubwonko n’imihangayiko (150mg buri mL ni 7,5x urwego rw’ubushakashatsi rwa 20mg).
• THCa: 1,500mg – Ikitanga ibikomera n’umubiri udafite ubwonko (cyangwa gihinduka ~1,315mg Delta-9 THC niba byashyushye).
• CBN: 750mg – Igifasha mu cyicaro n’uburara ku rwego rw’ubushakashatsi rwa 25mg/mL.
• CBC: 750mg – Umufasha wa neurogenesis n’urwego rw’abafatanyabikorwa.
• Delta-9 THC: <90mg – Ikomeza kujya Farm Bill (<0,3%).
• 5% Terpenes Zihariye: Kugira ngo haboneke ingaruka y’urwego rw’abafatanyabikorwa.

Iyi fomire igaragaza inzira enye zo kurwanya ibikomera (binyuze mu CB2, PPARγ, gukumira COX-2, na GABA) kandi iha umurwayi ubushobozi bwo gukora bishingiye ku buryo yakoreshejwe (nta siyanki) cyangwa decarboxylated.

Ikigereranyo cy’Igiciro cy’Imiti (Ibitekerezo by’Uburezi):
Kugira ngo usobanukirwe imiterere y’ubukungu mu buvuzi bwa cannabinoids, tekereza igiciro cy’imyaka:

• Epidiolex (CBD yemewe na FDA): $30,000 – $50,000
• Marinol (THC y’ubuhanga): $12,000 – $24,000
• Sativex (THC:CBD spray): $7,200 – $9,600
• Porotokole ya OilWell RSO (~4 bapfundo/umwaka): $519,96

Iyi mpinduka ikomeye igaragaza ikibazo cyo kugera ku buvuzi mu buvuzi bwa kigezi kandi ihagarariye intego y’ubushakashatsi bw’ibimera.

Ubwiza bw’Ubuhinzi n’Imyumvire y’Ibicuruzwa

Ishyirwa mu bikorwa ryacu rikomeza mu buhinzi bwacu. Dukoresha uburyo bwiza bwo guhinga udafite ibyoroshye, gukoresha urumuri rwuzuye rw’LED hamwe n’urumuri rwa UV-B, kandi dukoresha uburyo bwo kumva imyaka 60 byibuze mu mihango yagenewe (60°F, 60% RH). Buri gihingwa gikurikiza porogaramu y’ibintu 14 yo kugenzura binyuze mu kigo cy’ubushakashatsi, igenzura ubushobozi, ibintu byinshi (binyuze mu ICP-MS), 400+ pesticides, pathogens, n’ibisigazwa by’imiti.

Ibisobanuro by’Uburezi ku Buryo bwo Gukora Imiti

Umurimo wacu ku bijyanye n’uko ari ukora ibihingwa (ubwoko) bushyingiye ku mibare yazo ya cannabinoids na terpenes. Dore urugero rumwe rushobora gukoreshwa mu burezi:

• Pink Pineapple THCa Flower (35-38% THCa): Ikora mu buryo bworoshye (Pink Kush x Pineapple Express) ifite limonene na myrcene byinshi. Yashakishijwe ku bijyanye no gufasha mu kwitegura no gukora, itanga ubwoko bw’ikirenga budasanzwe nk’imiti yo mu buvuzi.
• Gorilla Glue #4 THCa Flower (25-30% THCa): Ikora mu buryo bworoshye ifite myrcene na beta-caryophyllene byinshi. Ibiranga beta-caryophyllene biri mu buryo bukomeye kubera ubushobozi bwayo kugira agonist ya CB2, bihuzwa n’ubushakashatsi bw’uburibwe n’ibikomera.
• Lemon Pound Cake THCa Flower (28-32% THCa): Ikorera mu buryo bworoshye ifite limonene byinshi (0,8-1,4%). Iyi mimerere ni urugero rwa mbere rw’ubushakashatsi bw’ingaruka y’urwego rw’abafatanyabikorwa, aho imiterere yayo ya terpenes ishobora guhindura uko ubushakashatsi bwarangira.
• Granddaddy Purple THCa Flower (26-30% THCa): Ikorera mu buryo bworoshye ifite myrcene na linalool byinshi. Irashobora kuba urugero rw’ubushakashatsi bw’ikirenga mu cyicaro n’uburara, hamwe n’ubushakashatsi bwa CBN.
• Sunset Fritter THCa Flower (33% THCa): Ikora mu buryo bworoshye yatsindiye igihembo ifite imiterere yoroshye ya terpenes. Ihagarariye ibigize imiterere y’ubushakashatsi bw’imiti bisobanura uburyo imimerere y’imiti ishobora gukorwa mu guhinga n’ubuhinzi bwa kino.

Gukorana n’Uburyo bwo mu Butaka: Intambwe izaza mu Buzima bw’Ibimera

Uburezi bwacu burgizemo ubunyobwa bwo mu butaka, bwakoreshejwe mu mitwarire y’amasomo y’ubuvuzi bwa kera imyaka irenga. Siyanse ya kigezi ubu irahasanga ubushobozi bwabyo bwo kugenza, kandi dusoma uburyo bwo gukorana na cannabinoids.

• Lion’s Mane (Hericium erinaceus): Yashakishijwe cyane mu gufasha mu gukora Nerve Growth Factor (NGF), bishobora gufasha mu bumenyi n’uburyo bwo gukora ibindi bintu.
• Reishi (Ganoderma lucidum): Yitwa “Umwamikazi w’Ubutaka”, yashakishijwe ku bijyanye n’uburyo bwo gukora sisitemu y’ubuzima n’uburyo bwo kugabanya ibintu.
• Cordyceps (Cordyceps militaris): Yashakishijwe ku bijyanye no kugira imbaraga mu gukora energie mu binyabuzima (ATP) n’gukoresha umwuka.
• Chaga (Inonotus obliquus): Ifite antioxidants nka superoxide dismutase (SOD) byinshi, yashakishijwe ku bijyanye n’uburyo bwo gufasha sisitemu y’ubuzima.

Dusura uburyo bwo guhuza ubunyobwa n’imiti idafite ubwonko, dusuzuma ingaruka zishobora kuba zifatanye mu gufasha mu buzima bwose, mu bumenyi, n’imihango. Ibi bireba uburyo bworoshye bwo kugenzura ubuzima busobanura imihango myinshi y’ibimera.

Umusaruro ku Isi no Gushyira mu Bikorwa ry’Uburezi

Nubwo dukora mu murwa mukuru wa Houston, muri Texas, dukurikiza amategeko y’igihugu n’amahanga ya Amerika, umusaruro wacu w’uburezi ni ku Isi hose. Twaremera ko gusobanukirwa sisitemu ya endocannabinoid y’umuntu n’imikorere y’imiti nk’cannabis n’ubunyobwa bwo mu butaka ni igice cy’ubumenyi bw’abantu.

Kuri inshuti zacu mu karere ka Ngozi no mu gihugu cya Burundi, dushyira aya makuru mu buryo bworoshye, duhakana amategeko y’igihugu. Dusangiza inkuru ya Bentley, ingoga y’isi yacu, n’ibisobanuro by’ubuzima bwacu kugira ngo tubashe gutanga ibitekerezo ku bijyanye n’imiti y’ibimera, ubushishozi bw’ubushakashatsi, n’ubuvuzi bwiza.

Ubuzima bw’ukuri butangira no gusanga. Turacyane nk’abigisha, dusangiza ibyo twize ku gahwa k’umusazi, ku murimo w’abahanga mu bya siyanse ku Isi yose, no mu bwenge bwa kera bw’ibimera ubwabyo.

Iyi nkuru ni ubucyo bw’uburezi na gahunda y’amakuru gusa. Ntabwo ari inama y’ubuvuzi. Usibye ibihe byose, usabye abahanga mu by’ubuvuzi mbere y’uko utangira gusoma nshya. Ntidusaba guhohotera amategeko y’igihugu cyangwa y’akarere, harimo n’ibya Burundi biziririje cannabis.

ENGLISH

Cannabis Science and Wellness Education for Ngozi Province: Exploring Nature’s Pharmacy with OilWell

Greetings to our friends and lifelong learners in Ngozi Province.

We are OilWell Cannabis, a mission-driven collective of scientists, herbalists, and educators based in Houston, Texas. While the vibrant hills and communities of Burundi’s northern highlands are far from our home, our commitment to global cannabis education transcends borders. We do not sell, ship, or promote the use of cannabis in regions where it is prohibited. Instead, we dedicate ourselves to sharing the profound scientific knowledge, historical context, and wellness principles derived from the cannabis plant and other botanicals like functional mushrooms. This information is presented for academic and educational purposes, respecting the sovereign laws of every nation, including Burundi’s strict prohibitions.

Our journey began not in a laboratory, but on the floor beside a paralyzed pitbull named Bentley. Facing veterinary recommendations for euthanasia, we discovered the untapped therapeutic potential of cannabinoids. This personal miracle—watching a dog pronounced unsaveable stand up, walk, and play after ten years—forged our ethos. We believe knowledge is fundamental, and understanding the body’s intrinsic endocannabinoid system is a human right, regardless of geography. This document serves as a comprehensive educational resource on the science of cannabinoids, terpenes, and functional fungi, detailing the rigorous pharmaceutical standards we uphold and the research that guides our philosophy. We share this from a place of humility and respect for Ngozi Province’s rich cultural heritage and legal framework.

Navigating Global Cannabis Realities: A Note on Legal Landscapes

The legal status of cannabis is a complex global tapestry, varying dramatically from one jurisdiction to another. In the United States, the 2018 Farm Bill created a federal framework distinguishing hemp (defined as cannabis with less than 0.3% Delta-9 THC by dry weight) from marijuana. This allowed for the legal cultivation, sale, and shipment of hemp-derived products, including novel cannabinoids like THCa and Delta-8 THC, provided they are sourced from compliant hemp. It is under this specific federal agricultural statute that our operations in Houston are conducted.

Conversely, in Burundi, cannabis in all forms remains strictly prohibited. The country adheres to stringent national laws and international drug control conventions that classify cannabis as an illicit substance. Penalties for possession, use, or distribution are severe. We explicitly and unequivocally state that this content is not an encouragement to violate Burundian law. It is an educational exploration of plant science, molecular biology, and the ongoing global shift in understanding these compounds. We acknowledge and respect the legal sovereignty of the Republic of Burundi and the authority of Ngozi Province within it.

Africa as a continent holds a deep and ancient relationship with the cannabis plant, Cannabis sativa, with historical uses documented across various cultures for ceremonial, textile, and wellness purposes. Today, the continental legal landscape is in flux. Neighboring countries are engaging in serious medical research and reform debates. While Burundi maintains its prohibitive stance, understanding the broader scientific conversation is valuable. Our purpose here is to contribute factual, research-backed information to that global dialogue, emphasizing safety, quality, and education over any form of promotion that conflicts with local law.

The Scientific Foundation: The Endocannabinoid System (ECS) – Your Body’s Universal Balance Keeper

To understand why cannabinoids from the cannabis plant interact with the human body, we must first understand a biological system discovered in the 1990s: the Endocannabinoid System (ECS). This is not a system for cannabis; it is a fundamental physiological system present in all humans and nearly all vertebrates, and it was named after the plant that helped scientists discover it.

The ECS is a vast network of chemical signals and receptors (CB1 and CB2) that permeates your brain and body. Its primary function is homeostasis—maintaining a stable internal environment despite external fluctuations. Think of it as the body’s master regulator for:

• Pain Perception and Inflammation
• Mood, Stress, and Emotional Response
• Sleep Cycles and Energy Balance
• Memory and Learning
• Appetite and Digestion
• Immune System Function
• Motor Control and Coordination

Your body produces its own cannabinoids, called endocannabinoids (like anandamide, the “bliss molecule”). Plant-derived cannabinoids, or phytocannabinoids, are structurally similar. When introduced, they can interact with this existing system, supporting its regulatory functions. This explains the wide range of potential applications for cannabis compounds—they are engaging with the very system tasked with keeping you in balance.

A Deep Dive into Key Cannabinoids: Molecular Science and Research

What follows is an educational breakdown of primary cannabinoids, their molecular structures, and the peer-reviewed research that informs our understanding of their interactions with the ECS. This is the core of our academic mission.

1. Cannabidiol (CBD) – The Foundation of Modern Cannabis Research

• Molecular Formula: C₂₁H₃₀O₂
• Discovery: Isolated in 1940 by Dr. Roger Adams at the University of Illinois.
• Scientific Profile: CBD is non-intoxicating and interacts with a wide array of receptor systems beyond just CB1 and CB2. It acts as an allosteric modulator of the CB1 receptor (meaning it can change how the receptor responds to other signals), a potent agonist of the 5-HT1A serotonin receptor (involved in anxiety and mood), and an activator of TRPV1 channels (involved in pain and inflammation perception).
• Landmark Research: The most significant validation came with the 2018 FDA approval of Epidiolex, a purified CBD medication, for severe childhood seizure disorders like Dravet and Lennox-Gastaut syndromes. A 2017 review by the National Academies of Sciences, Engineering, and Medicine, which analyzed over 17,000 studies, concluded there is “conclusive or substantial evidence” that cannabis is effective for chronic pain in adults and chemotherapy-induced nausea.
• Safety Note: CBD is a potent inhibitor of certain cytochrome P450 enzymes in the liver (particularly CYP2C19 and CYP3A4). This is critical pharmaceutical knowledge, as it means CBD can alter the metabolism and plasma levels of many common medications, including blood thinners (warfarin), seizure drugs (clobazam), and some antidepressants. Responsible education must include this information.

2. Tetrahydrocannabinolic Acid (THCa) – The Precursor with Unique Potential

• Molecular Formula: C₂₂H₃₀O₄
• The Science of Conversion: In the raw cannabis plant, over 90% of the potential THC exists as THCa, a carboxylic acid. Through a process called decarboxylation—applying heat (like smoking, vaping, or baking)—the acid group is removed as CO₂, converting THCa into psychoactive Delta-9 THC. The conversion is roughly 87.7% efficient.
• Dual-Pathway Education: This chemistry creates two distinct avenues:
  • Raw/Unheated THCa: When consumed orally (e.g., in a tincture or fresh juice), it is non-psychoactive. Pioneering research, including studies from the National Institutes of Health (NIH), suggests THCa itself has powerful properties. A 2023 NIH study indicated it is responsible for the majority of anti-inflammatory activity in colon inflammation models via COX-2 inhibition. A 2024 NIH study identified THCa as a potent PPARγ receptor agonist, a pathway crucial for regulating inflammation, insulin sensitivity, and cellular health, and noted its neuroprotective capabilities.
  • Heated/Decarboxylated THCa: This becomes Delta-9 THC, engaging the classic CB1 receptor pathways.
• Legal Context in the U.S.: Because U.S. federal law (the 2018 Farm Bill) only limits Delta-9 THC content in hemp, high-THCa hemp flower and products are cultivated and sold in a federally compliant manner. This is a cornerstone of the modern U.S. hemp industry.

3. Cannabigerol (CBG) – “The Mother Cannabinoid”

• Molecular Formula: C₂₁H₃₂O₂
• Biosynthetic Role: In the plant, all major cannabinoids (THC, CBD, CBC) start as cannabigerolic acid (CBGa), earning CBG its “mother” title. It is typically found in very low concentrations (<1%) in mature plants.
• Multifaceted Receptor Interaction: CBG shows affinity for both CB1 and CB2 receptors, but its promising research lies beyond. It acts as an agonist for the alpha-2 adrenergic receptor (similar to certain anti-anxiety and blood pressure medications) and a potent GABA reuptake inhibitor. GABA is the brain’s primary inhibitory neurotransmitter; increasing its availability is a mechanism of action for anti-anxiety medications like benzodiazepines, but without the same receptor binding.
• Recent Research Highlights: A groundbreaking 2024 double-blind, placebo-controlled study from Washington State University (N=34) found that just 20mg of CBG significantly reduced anxiety. Remarkably, the same study found CBG enhanced memory—the opposite effect commonly associated with THC. Additional NIH-affiliated studies in 2024 highlighted CBG’s neuroprotective effects against amyloid-beta toxicity (relevant to Alzheimer’s research) and its potent antibacterial activity against resistant pathogens like MRSA.

4. Cannabinol (CBN) – The Sedative Pioneer

• Molecular Formula: C₂₁H₂₆O₂
• Formation: CBN is primarily a degradation product of THC, formed as cannabis ages or is exposed to oxygen and heat.
• Sleep Science Breakthrough: For decades, CBN’s reputation as a sedative was anecdotal. In late 2024, researchers at the University of Sydney published the first objective, empirical evidence in animal models showing CBN increased both NREM and REM sleep stages, with effects comparable to zolpidem (Ambien). This was followed by a large-scale human randomized controlled trial (Oxford Academic, April 2024, N=1000+) which concluded that 50mg of CBN significantly improved sleep metrics compared to a placebo. This positions CBN as the first cannabinoid with robust, emerging clinical data for sleep support.

5. Cannabichromene (CBC) – The Neurogenesis Supporter

• Molecular Formula: C₂₁H₃₀O₂
• Unique Mechanism: Unlike THC or CBD, CBC has low binding affinity for CB1/CB2. Instead, it powerfully activates TRPV1 and TRPA1 receptors (key players in pain signaling) and is a potent inhibitor of anandamide reuptake, effectively increasing levels of our body’s own “bliss” cannabinoid.
• Promising Research: A significant 2024 review from Penn State University highlighted its “unique therapeutic potential.” Earlier work, such as a 2013 study in Neurochemistry International, demonstrated that CBC positively influences the maturation of adult neural stem progenitor cells (NSPCs), promoting neurogenesis (the creation of new neurons) in the hippocampus, a brain region vital for memory and learning.

6. Delta-8-Tetrahydrocannabinol (Delta-8 THC) – The Milder Psychotropic Isomer

• Molecular Formula: C₂₁H₃₀O₂ (an isomer of Delta-9 THC)
• Profile: Delta-8 THC occurs in trace amounts naturally but is typically produced by converting CBD from hemp. It binds to the CB1 receptor with lower affinity than Delta-9 THC, resulting in effects often described as clearer and less anxious.
• Research-Backed Profile: A 2022 study in the Journal of Cannabis Research (N=521) surveyed users across 38 U.S. states. It found 74% reported no anxiety and 83% reported no paranoia from Delta-8 use, compared to their experiences with Delta-9. Historical research includes a notable 1995 pediatric study where Delta-8 THC was 100% effective in preventing chemotherapy-induced vomiting in children aged 3-13, with zero psychoactive effects reported.

7. The Critical Role of Terpenes: The Entourage Effect Validated

Terpenes are aromatic compounds found in all plants, responsible for the distinctive scents of cannabis strains, pine forests, and citrus fruits. They are not unique to cannabis but play a vital synergistic role.

• Myrcene: The most common terpene in modern cannabis. Preclinical research suggests sedative and muscle-relaxant properties. It is also believed to increase the permeability of the blood-brain barrier, potentially allowing cannabinoids to cross more efficiently.
• Limonene: Found in citrus rinds. A landmark 2024 double-blind, placebo-controlled study from Johns Hopkins University (N=20) provided the first clinical proof of the entourage effect. It found that participants who consumed 15mg of D-limonene terpene alongside 30mg of THC experienced a 54.8% greater reduction in “anxious/nervous” feelings and “paranoid” feelings compared to THC alone. This is revolutionary, concrete evidence that terpenes actively modulate cannabinoid effects.
• Beta-Caryophyllene (BCP): A dietary terpene found in black pepper and cloves. It is unique as the only known terpene that directly binds to the CB2 receptor, producing anti-inflammatory effects without psychoactivity. Research in 2024 highlighted its role in reducing pro-inflammatory cytokines (like TNF-α and IL-6) and its neuroprotective potential in models of Parkinson’s and Alzheimer’s disease.
• Linalool: Prominent in lavender. It interacts with GABA receptors, promoting relaxation. Studies on post-surgical patients inhaling lavender oil (rich in linalool) showed they required significantly less morphine for pain.

The combined, synergistic interaction of cannabinoids and terpenes—where the whole plant’s effect is greater than the sum of its isolated parts—is known as The Entourage Effect. The Johns Hopkins limonene study is a seminal piece of evidence for this principle.

The OilWell Genesis: From a Paralyzed Dog to Pharmaceutical-Grade Mission

Our entire company philosophy was born from a personal medical crisis. Our founder’s pitbull, Bentley, was paralyzed in his hind legs and faced euthanasia as the only veterinary option, as pain medications would have destroyed his organs. A chance question from a rescue worker—”You’ve moved how many tons of weed and you’ve never heard of CBD?”—ignited a desperate quest for knowledge.

Through relentless research and formulation, a “golden paste” was created: a precise blend of organic turmeric, coconut oil, black pepper (for bioavailability), and carefully dosed CBD oil. The result defied all expectations. Bentley, paralyzed for months, stood up, walked, and brought his ball to play. He lived for ten additional full, active years, passing away peacefully at age 20.

Those ten years were our research and development phase. As Bentley aged, we developed specific formulas for his neurodegeneration, arthritis, and glaucoma. Every OilWell product today is an evolution of those compassionate, precision formulations. This story is why we operate with a “patient-first” mentality, why we prioritize education over sales, and why our commitment to quality is non-negotiable. It was featured by ABC News in Houston, establishing our reputation not as dealers, but as educators.

Mainstream Media Recognition: A Commitment to Transparency

Our educational work has been featured multiple times by ABC13 News in Houston, a testament to our legitimate, above-board approach:

• In 2019, we emphasized educating consumers and combating “snake oil” products in the burgeoning CBD market.
• In 2021, we provided expert analysis on Delta-8 THC, honestly discussing its effects while navigating complex legal grey areas.
• That same year, we demonstrated community commitment by giving away over $35,000 in products as an incentive for COVID-19 vaccinations, prioritizing public health over profit.
• We have consistently advocated for sensible cannabis policy reform, with our founder speaking openly about past charges to highlight the need for criminal justice change.

The Pinnacle of Formulation: Rick Simpson Oil (RSO) Reimagined

The Rick Simpson Oil (RSO) story is a crucial chapter in cannabis history. In the early 2000s, Canadian engineer Rick Simpson used homemade, concentrated cannabis oil to treat his own skin cancers, reporting remarkable success. His “60-gram protocol” and advocacy spread globally through the documentary “Run From the Cure.” However, traditional RSO faced challenges: illegal status, harsh taste, inconsistent potency, and the use of dangerous solvents.

Our mission was to create a pharmaceutical-grade, federally compliant version that honored Simpson’s full-spectrum principle while solving these problems. Our THCa Rick Simpson Oil is the culmination of that mission.

Our Revolutionary THCa RSO Formulation (Sublingual Oil):
Each 30mL bottle contains 16,590mg of total cannabinoids, a precise six-cannabinoid symphony:

• CBD: 4,500mg – Anxiolytic, anti-inflammatory foundation.
• Delta-8 THC: 6,000mg – Primary psychoactive with reduced anxiety profile.
• CBG: 3,000mg – “Mother cannabinoid” for neuroprotection and anxiety (150mg per mL is 7.5x the clinically studied 20mg dose).
• THCa: 1,500mg – Non-psychoactive anti-inflammatory and neuroprotective agent (or converts to ~1,315mg Delta-9 THC if heated).
• CBN: 750mg – Sleep and relaxation support at the studied 25mg/mL dose.
• CBC: 750mg – Neurogenesis and entourage support.
• Delta-9 THC: <90mg – Maintains full Farm Bill compliance (<0.3%).
• 5% Live Terpenes: For the validated entourage effect.

This formula represents a four-pathway anti-inflammatory attack (via CB2, PPARγ, COX-2 inhibition, and GABA) and allows for patient-controlled potency based on whether it’s used raw (non-psychoactive) or decarboxylated.

Pharmaceutical Cost Comparison (Educational Perspective):
To understand the economic context of cannabinoid medicine, consider annual costs:

• Epidiolex (FDA-approved CBD): $30,000 – $50,000
• Marinol (synthetic THC): $12,000 – $24,000
• Sativex (THC:CBD spray): $7,200 – $9,600
• OilWell RSO Protocol (~4 bottles/year): $519.96

This stark contrast highlights the accessibility crisis in modern medicine and frames the mission of plant-based research.

Premium Cultivation and Product Philosophy

Our commitment extends to our cultivation. We utilize living soil organic practices, full-spectrum LED lighting with UV-B enhancement, and a mandatory 60-day minimum cure in controlled environments (60°F, 60% RH). Every batch undergoes a 14-point verification process via third-party laboratories, testing for potency, heavy metals (via ICP-MS), 400+ pesticides, microbial pathogens, and residual solvents.

Educational Overview of Strain-Specific Formulations

Our work with specific cultivars (strains) is based on their unique cannabinoid and terpene profiles. Here are several examples used for educational purposes:

• Pink Pineapple THCa Flower (35-38% THCa): A balanced hybrid (Pink Kush x Pineapple Express) high in limonene and myrcene. Studied for potential applications in focus and executive function support, offering a natural profile distinct from pharmaceutical stimulants.
• Gorilla Glue #4 THCa Flower (25-30% THCa): A classic hybrid rich in myrcene and beta-caryophyllene. The caryophyllene content is of particular interest due to its direct CB2 agonist activity, relevant for pain and inflammation research.
• Lemon Pound Cake THCa Flower (28-32% THCa): A sativa-dominant hybrid with exceptionally high limonene content (0.8-1.4%). This strain is a prime example for studying the Johns Hopkins-entourage effect, where its natural terpene profile may modulate the experience.
• Granddaddy Purple THCa Flower (26-30% THCa): A pure indica rich in myrcene and linalool. It serves as a botanical example for research into sleep and deep relaxation, alongside the study of CBN.
• Sunset Fritter THCa Flower (33% THCa): An award-winning hybrid with a balanced terpene profile. It exemplifies the complex phytochemistry that can result from careful breeding and cultivation.

Functional Mushroom Synergy: The Next Frontier in Botanical Wellness

Our educational scope includes functional mushrooms, which have been used in traditional medicine systems for millennia. Modern science is now validating their adaptogenic properties, and we study their potential synergy with cannabinoids.

• Lion’s Mane (Hericium erinaceus): Extensively researched for supporting nerve growth factor (NGF) synthesis, potentially aiding cognitive function and neuroregeneration.
• Reishi (Ganoderma lucidum): Known as the “Queen of Mushrooms,” studied for its immunomodulating and calming adaptogenic properties.
• Cordyceps (Cordyceps militaris): Researched for its potential to enhance cellular energy production (ATP) and oxygen utilization.
• Chaga (Inonotus obliquus): Rich in antioxidants like superoxide dismutase (SOD), studied for its immune-supporting properties.

We explore formulations that combine these mushrooms with non-psychoactive cannabinoids, investigating potential synergistic benefits for overall system resilience, cognitive support, and stress adaptation. This represents a holistic approach to wellness that looks at multiple kingdoms of nature.

Global Mission and Educational Commitment

While our physical operations are in Houston, Texas, operating in full compliance with U.S. federal and state law, our educational mission is global. We believe that understanding the human endocannabinoid system and the pharmacopeia of plants like cannabis and functional mushrooms is part of a broader human knowledge base.

For our friends in Ngozi Province and across Burundi, we offer this information respectfully, acknowledging your nation’s laws. We share the story of Bentley, the rigor of our science, and the details of our standards to contribute to a fact-based, global conversation about plant medicine, research ethics, and compassionate care.

True wellness begins with knowledge. We are here as educators, sharing what we have learned from a pitbull who refused to give up, from the meticulous work of scientists worldwide, and from the ancient wisdom of the plants themselves.

This content is for educational and informational purposes only. It is not medical advice. Always consult with a qualified healthcare professional before starting any new wellness regimen. We do not advocate for the violation of any national or local laws, including the strict prohibitions on cannabis in Burundi.